Retracted: Targeting AraC-Resistant Acute Myeloid Leukemia by Dual Inhibition of CDK9 and Bcl-2: A Systematic Review and Meta-Analysis
- PMID: 37593493
- PMCID: PMC10432048
- DOI: 10.1155/2023/9823939
Retracted: Targeting AraC-Resistant Acute Myeloid Leukemia by Dual Inhibition of CDK9 and Bcl-2: A Systematic Review and Meta-Analysis
Abstract
[This retracts the article DOI: 10.1155/2022/2842066.].
Copyright © 2023 Journal of Healthcare Engineering.
Retraction of
-
Targeting AraC-Resistant Acute Myeloid Leukemia by Dual Inhibition of CDK9 and Bcl-2: A Systematic Review and Meta-Analysis.J Healthc Eng. 2022 Jan 25;2022:2842066. doi: 10.1155/2022/2842066. eCollection 2022. J Healthc Eng. 2022. Retraction in: J Healthc Eng. 2023 Aug 9;2023:9823939. doi: 10.1155/2023/9823939. PMID: 35126914 Free PMC article. Retracted.
References
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous